27 Phase III and 8 Phase II Alzheimer's drugs on track to launch in next five years

Twenty-seven Alzheimer’s drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years, according to a revised Alzheimer’s pipeline analysis presented today at the Alzheimer’s Association International Conference (AAIC) by ResearchersAgainstAlzheimer’s (RA2), an UsAgainstAlzheimer’s network.

from Dementia Big http://ift.tt/2tlCm8E via alcoholic dementia

http://ift.tt/2uHhSr8